$AMRN
AMARIN CORP PLC\UK

2016 Q4 Form 10-K Financial Statement

#000119312517065969 Filed on March 01, 2017

View on sec.gov

Income Statement

Concept 2016 Q4 2016 2015 Q4
Revenue $38.70M $130.1M $26.63M
YoY Change 45.29% 59.11% 61.61%
Cost Of Revenue $10.20M $34.36M $8.400M
YoY Change 21.43% 23.28% 44.83%
Gross Profit $28.50M $95.72M $18.20M
YoY Change 56.59% 77.65% 71.7%
Gross Profit Margin 73.65% 73.58% 68.34%
Selling, General & Admin $31.20M $111.4M $23.50M
YoY Change 32.77% 10.22% 27.72%
% of Gross Profit 109.47% 116.35% 129.12%
Research & Development $10.20M $49.98M $13.30M
YoY Change -23.31% -2.13% 7.26%
% of Gross Profit 35.79% 52.21% 73.08%
Depreciation & Amortization $200.0K $100.0K $210.0K
YoY Change -4.76% -50.0% 0.0%
% of Gross Profit 0.7% 0.1% 1.15%
Operating Expenses $41.40M $161.3M $36.80M
YoY Change 12.5% 6.08% 19.09%
Operating Profit -$12.90M -$65.63M -$18.60M
YoY Change -30.65% -33.19% -8.37%
Interest Expense -$2.200M $18.68M -$6.000M
YoY Change -63.33% -7.45% 76.47%
% of Operating Profit
Other Income/Expense, Net -$100.0K -$482.0K -$100.0K
YoY Change 0.0% 111.4% -50.0%
Pretax Income -$15.20M -$76.38M -$23.40M
YoY Change -35.04% -35.43% -1.68%
Income Tax $12.30M $9.969M -$1.500M
% Of Pretax Income
Net Earnings -$27.45M -$86.35M -$21.89M
YoY Change 25.41% -25.05% 11.36%
Net Earnings / Revenue -70.95% -66.38% -82.2%
Basic Earnings Per Share -$0.10 -$0.41 -$0.12
Diluted Earnings Per Share -$0.10 -$0.41 -$0.12
COMMON SHARES
Basic Shares Outstanding 211.9M
Diluted Shares Outstanding 211.9M

Balance Sheet

Concept 2016 Q4 2016 2015 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $98.30M $98.30M $107.0M
YoY Change -8.13% -8.13% -10.46%
Cash & Equivalents $98.25M $98.30M $107.0M
Short-Term Investments
Other Short-Term Assets $7.600M $7.600M $3.800M
YoY Change 100.0% 100.0% 44.32%
Inventory $20.51M $20.50M $18.99M
Prepaid Expenses
Receivables $19.99M $20.00M $13.83M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $146.3M $146.3M $143.5M
YoY Change 1.95% 1.95% -1.21%
LONG-TERM ASSETS
Property, Plant & Equipment $78.00K $100.0K $243.0K
YoY Change -67.9% -50.0% -36.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $741.0K $11.80M $174.0K
YoY Change 325.86% -41.0% -93.84%
Total Long-Term Assets $20.67M $20.70M $29.71M
YoY Change -30.41% -30.3% 15.02%
TOTAL ASSETS
Total Short-Term Assets $146.3M $146.3M $143.5M
Total Long-Term Assets $20.67M $20.70M $29.71M
Total Assets $167.0M $167.0M $173.2M
YoY Change -3.6% -3.58% 1.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.062M $6.100M $10.83M
YoY Change -44.04% -43.52% 27.06%
Accrued Expenses $37.70M $31.90M $24.20M
YoY Change 55.79% 60.3% 48.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $15.94M $31.30M $12.48M
YoY Change 27.8% 112.93% -18.96%
Total Short-Term Liabilities $76.25M $76.20M $50.72M
YoY Change 50.32% 50.3% 25.84%
LONG-TERM LIABILITIES
Long-Term Debt $85.16M $85.20M $91.51M
YoY Change -6.95% -63.96% 2.11%
Other Long-Term Liabilities $710.0K $14.70M $335.0K
YoY Change 111.94% 8.09% -13.21%
Total Long-Term Liabilities $85.87M $99.90M $91.85M
YoY Change -6.51% -60.04% 2.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $76.25M $76.20M $50.72M
Total Long-Term Liabilities $85.87M $99.90M $91.85M
Total Liabilities $176.1M $176.1M $300.8M
YoY Change -41.47% -41.46% 15.88%
SHAREHOLDERS EQUITY
Retained Earnings -$1.204B -$1.118B
YoY Change 7.73% 15.19%
Common Stock $1.172B $966.1M
YoY Change 21.31% 9.54%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.498M $411.0K
YoY Change 264.48% 89.4%
Treasury Stock Shares $819.5K 174.5K shares
Shareholders Equity -$9.058M -$9.100M -$129.2M
YoY Change
Total Liabilities & Shareholders Equity $167.0M $167.0M $173.2M
YoY Change -3.6% -3.58% 1.24%

Cashflow Statement

Concept 2016 Q4 2016 2015 Q4
OPERATING ACTIVITIES
Net Income -$27.45M -$86.35M -$21.89M
YoY Change 25.41% -25.05% 11.36%
Depreciation, Depletion And Amortization $200.0K $100.0K $210.0K
YoY Change -4.76% -50.0% 0.0%
Cash From Operating Activities -$19.32M -$71.82M -$23.21M
YoY Change -16.76% -14.53% 45.79%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $21.00K -$20.00K
YoY Change -100.0% -25.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$21.00K -$20.00K
YoY Change -100.0% -30.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $64.61M
YoY Change 33205.67%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 63.13M 11.22M
YoY Change -100.0% -11.67% 56000.0%
NET CHANGE
Cash From Operating Activities -19.32M -71.82M -23.21M
Cash From Investing Activities 0.000 -21.00K -20.00K
Cash From Financing Activities 0.000 63.13M 11.22M
Net Change In Cash -19.32M -8.710M -12.01M
YoY Change 60.87% -30.76% -24.47%
FREE CASH FLOW
Cash From Operating Activities -$19.32M -$71.82M -$23.21M
Capital Expenditures $0.00 $21.00K -$20.00K
Free Cash Flow -$19.32M -$71.84M -$23.19M
YoY Change -16.69% -14.53% 45.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2015Q1 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
0.1 shares
CY2015Q1 us-gaap Share Price
SharePrice
2.39
CY2016Q2 dei Entity Public Float
EntityPublicFloat
381800000
CY2015Q2 amrn Private Placement Issuance Number Of Tranches
PrivatePlacementIssuanceNumberOfTranches
2 Tranche
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-33856000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1674000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
191514000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.03
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-88448000
CY2014Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
7519000
CY2014Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
7090000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2487000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
85965000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119539000
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
328184640 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.12
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
243000
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
174502 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
183403263 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
183577765 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
328184640 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
17818000 shares
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.76
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2015Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1400000
CY2015Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
136734000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1117654000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
24364000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
335000
CY2015Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
87700000
CY2015Q4 us-gaap Liabilities
Liabilities
300782000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
173230000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5241000
CY2015Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
8170000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
923000
CY2015Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3141000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10832000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-127552000
CY2015Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
2266000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
91512000
CY2015Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
8170000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
13308000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
149978000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
816171000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
754000
CY2015Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
15796000
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1550000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4284000
CY2015Q4 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
11500000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
24226000
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
12476000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
91512000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50723000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
95999000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
143524000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
2796000
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1640000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
17975000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
997000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
600000
CY2015Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
18270000
CY2015Q4 us-gaap Assets
Assets
173230000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
115871000
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
19872000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106961000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
88996000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
6030000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
19872000
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
19872000
CY2015Q4 us-gaap Inventory Net
InventoryNet
18985000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13826000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9417000
CY2015Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
9096000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8249000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
174000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3152000
CY2015Q4 us-gaap Treasury Stock Value
TreasuryStockValue
411000
CY2015Q4 amrn Accrued Liabilities Sales Allowances Current
AccruedLiabilitiesSalesAllowancesCurrent
10732000
CY2015Q4 amrn Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
74000
CY2015Q4 amrn Research And Development Accrued Expense Current
ResearchAndDevelopmentAccruedExpenseCurrent
828000
CY2015Q4 amrn Preferred Stock Equivalent Ordinary Shares Upon Future Conversion Outstanding
PreferredStockEquivalentOrdinarySharesUponFutureConversionOutstanding
32818464 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
328184640 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.09
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.41
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
819505 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
269363696 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4304000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
20513000 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
270183201 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
328184640 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
10143176 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
12217000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.38
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
21188014 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.37
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2016Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1500000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
166999000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6611000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1204004000
CY2016Q4 us-gaap Purchase Obligation
PurchaseObligation
44600000
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
24364000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
710000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
126000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
654000
CY2016Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
90500000
CY2016Q4 us-gaap Liabilities
Liabilities
176057000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1172000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1050000
CY2016Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
2821000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6062000
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
-9058000
CY2016Q4 us-gaap Senior Notes Current
SeniorNotesCurrent
15351000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
528000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
85155000
CY2016Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
13943000
CY2016Q4 us-gaap Deferred Revenue
DeferredRevenue
15100000
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
207166000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
964914000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
755000
CY2016Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
27198000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1633000
CY2016Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
25100000
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5800000
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2852000
CY2016Q4 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
11500000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
37720000
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
15944000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
85155000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
76249000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
109274000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
146326000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
2437000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10716000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78000
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7159000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
98251000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
88345000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
6893000
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11082000
CY2016Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
11082000
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
11800000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
646000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
646000
CY2016Q4 us-gaap Inventory Net
InventoryNet
20507000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
16396000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19985000
CY2016Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
12000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
23731000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
821000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
600000
CY2016Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
24127000
CY2016Q4 us-gaap Assets
Assets
166999000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
121406000
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
12132000
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8772000
CY2016Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
11624000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
5542000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
646000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
646000
CY2016Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
646000
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4430000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5361000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
741000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6983000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17018000
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1498000
CY2016Q4 amrn Operating Leases Future Minimum Payments Due In Three Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueInThreeYearsAndThereafter
0
CY2016Q4 amrn Accrued Liabilities Sales Allowances Current
AccruedLiabilitiesSalesAllowancesCurrent
22195000
CY2016Q4 amrn Research And Development Accrued Expense Current
ResearchAndDevelopmentAccruedExpenseCurrent
293000
CY2016Q4 amrn Write Offs Of Accounts Receivables
WriteOffsOfAccountsReceivables
0
CY2016Q4 amrn Deferred Tax Liabilities Depreciation And Amortization
DeferredTaxLiabilitiesDepreciationAndAmortization
1050000
CY2016Q4 amrn Deferred Tax Liabilities Subject To Expiration
DeferredTaxLiabilitiesSubjectToExpiration
59000
CY2016Q4 amrn Deferred Tax Assets Operating Loss Carryforwards Change In Amount
DeferredTaxAssetsOperatingLossCarryforwardsChangeInAmount
8100000
CY2016Q4 amrn Cash Discount Percent
CashDiscountPercent
0.02 pure
CY2016Q4 amrn Preferred Stock Equivalent Ordinary Shares Upon Future Conversion Outstanding
PreferredStockEquivalentOrdinarySharesUponFutureConversionOutstanding
32818464 shares
CY2016Q4 amrn Convertible Debt Carrying Value Exchanged
ConvertibleDebtCarryingValueExchanged
127300000
CY2015Q1 amrn Private Placement Closing Date
PrivatePlacementClosingDate
2015-03-30
CY2014 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-74608000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.09 pure
CY2014 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
173824000 shares
CY2014 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
173719000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.97 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0137 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.58
CY2014 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0168 pure
CY2014 us-gaap Interest Paid
InterestPaid
10033000
CY2014 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-10100000
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
54202000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-95955000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-56364000
CY2014 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
105000 shares
CY2014 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
-3034000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
8100000
CY2014 us-gaap Revenues
Revenues
54202000
CY2014 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
36000
CY2014 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4014000
CY2014 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
38034000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-12958000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4197000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9022000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1067000
CY2014 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2480000
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
96000
CY2014 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1455000
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
781000
CY2014 us-gaap Gross Profit
GrossProfit
33717000
CY2014 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
13472000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
307000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3727000
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-56364000
CY2014 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-63139000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1053000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7331000
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59201000
CY2014 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-6775000
CY2014 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3689000
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3614000
CY2014 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-226000
CY2014 us-gaap Depreciation
Depreciation
200000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2837000
CY2014 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
10026000
CY2014 us-gaap Interest Expense
InterestExpense
18575000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
9022000
CY2014 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
254000
CY2014 us-gaap Adjustments To Additional Paid In Capital Income Tax Deficiency From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation
2299000
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
660000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
777000
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
9493000
CY2014 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
198000
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-14786000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1703000
CY2014 us-gaap Restricted Stock Expense
RestrictedStockExpense
1400000
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
79346000
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5863000
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1073000
CY2014 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
8811000
CY2014 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
2420000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2633000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1000000
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1651000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
50326000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
646000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-71975000
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
20485000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
117000
CY2014 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
3335000
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
132000
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3034000
CY2014 us-gaap Operating Expenses
OperatingExpenses
129672000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
307000
CY2014 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7700000
CY2014 amrn Income Tax Reconciliation Derivative Liabilities
IncomeTaxReconciliationDerivativeLiabilities
-2706000
CY2014 amrn Repurchase Of Conversion Options On Long Term Debt
RepurchaseOfConversionOptionsOnLongTermDebt
10100000
CY2014 amrn Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
1651000
CY2014 amrn Income Tax Reconciliation Gain Loss On Extinguishment Of Debt
IncomeTaxReconciliationGainLossOnExtinguishmentOfDebt
-9509000
CY2014 amrn Proceeds From Refund Of Stock Issuance Costs
ProceedsFromRefundOfStockIssuanceCosts
3191000
CY2014 amrn Adjustments To Additional Paid In Capital Stock Issued Issuance Costs Refund
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCostsRefund
3191000
CY2014 amrn Income Tax Rate Reconciliation Cumulative Translation Adjustment Amount
IncomeTaxRateReconciliationCumulativeTranslationAdjustmentAmount
8061000
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.83
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-84021000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.97 pure
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
180654000 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
180654000 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.86 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0137 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.16
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.83
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.45
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.12
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0168 pure
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
18020 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.14
CY2015 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
8719000
CY2015 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
56229000
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
16291000
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-194000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
9100000
CY2015 us-gaap Revenues
Revenues
81756000
CY2015 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
5000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28000
CY2015 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-431000
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1314000
CY2015 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-1300000
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-187000
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
80987000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-98222000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-115204000
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1284000
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
711000
CY2015 us-gaap Interest Paid
InterestPaid
12559000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5252000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5984000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13872000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
144000
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
194000
CY2015 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
109000
CY2015 us-gaap Licenses Revenue
LicensesRevenue
769000
CY2015 us-gaap Gross Profit
GrossProfit
53881000
CY2015 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-149059000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
519000
CY2015 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1106000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
120000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-10137000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-118290000
CY2015 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
16145000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-228000
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-149059000
CY2015 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
727000
CY2015 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
4804000
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3343000
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4252000
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-605000
CY2015 us-gaap Depreciation
Depreciation
200000
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3086000
CY2015 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
2248000
CY2015 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
1368000
CY2015 us-gaap Interest Expense
InterestExpense
20180000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-28000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
13889000
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
439000
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1053000
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1166000
CY2015 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
166000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-29572000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
14231000
CY2015 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-51000
CY2015 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
57666000
CY2015 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
27514000
CY2015 us-gaap Restricted Stock Expense
RestrictedStockExpense
6000000
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
101041000
CY2015 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
40626000
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
8258000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1594000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-1033000
CY2015 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
10489000
CY2015 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-652000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
71471000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
800000
CY2015 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
32987000
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2713000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51062000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
6000
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
762000
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
646000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-12578000
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
27875000
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
113000
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-9023000
CY2015 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
8572000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
8719000
CY2015 us-gaap Operating Expenses
OperatingExpenses
152103000
CY2015 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
868000
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31000
CY2015 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
7900000
CY2015 amrn Income Tax Reconciliation Derivative Liabilities
IncomeTaxReconciliationDerivativeLiabilities
187000
CY2015 amrn Stock Issued During Period Shares Stock Warrants Exercised
StockIssuedDuringPeriodSharesStockWarrantsExercised
1844585 shares
CY2015 amrn Derivative Liabilities Transferred To Stockholders Equity
DerivativeLiabilitiesTransferredToStockholdersEquity
1814000
CY2015 amrn Repurchase Of Conversion Options On Long Term Debt
RepurchaseOfConversionOptionsOnLongTermDebt
1300000
CY2015 amrn Valuation Allowances And Reserves Charged To Earnings
ValuationAllowancesAndReservesChargedToEarnings
1315000
CY2015 amrn Derivative Liabilities Transferred To Equity Classifications
DerivativeLiabilitiesTransferredToEquityClassifications
868000
CY2015 amrn Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
2713000
CY2015 amrn Income Tax Reconciliation Gain Loss On Extinguishment Of Debt
IncomeTaxReconciliationGainLossOnExtinguishmentOfDebt
-328000
CY2015 amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
-449000
CY2015 amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
6448000
CY2015 amrn Preferred Stock Purchase Option
PreferredStockPurchaseOption
946000
CY2015 amrn Income Tax Rate Reconciliation Cumulative Translation Adjustment Amount
IncomeTaxRateReconciliationCumulativeTranslationAdjustmentAmount
7811000
CY2015 amrn Valuation Allowances And Reserves Foreign Currency Translation
ValuationAllowancesAndReservesForeignCurrencyTranslation
-7572000
CY2015 amrn Proceeds From Warrant Exercises Gross
ProceedsFromWarrantExercisesGross
2800000
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Document Type
DocumentType
10-K
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0000897448
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2016 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P13Y7M6D
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-71815000
CY2016 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
165000 shares
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.86 pure
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.62
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
7.24
CY2016 dei Trading Symbol
TradingSymbol
AMRN
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
211874000 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211874000 shares
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 18px"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i><u>Concentration of Credit Risk</u></i></b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px"><font style="FONT-FAMILY: Times New Roman" size="2">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents and accounts receivable. The Company maintains substantially all of its cash and cash equivalents in financial institutions believed to be of high-credit quality.</font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 12px"><font style="FONT-FAMILY: Times New Roman" size="2">A significant portion of the Company&#x2019;s sales are to wholesalers in the pharmaceutical industry. The Company monitors the creditworthiness of customers to whom it grants credit terms and has not experienced any credit losses. The Company does not require collateral or any other security to support credit sales. The Company&#x2019;s top three customers accounted for 95% of gross product sales for each of the years ending December&#xA0;31, 2016 and 2015, and represented 96% and 95% of the gross accounts receivable balance as of December&#xA0;31, 2016 and 2015, respectively. The Company has not experienced any write-offs of its accounts receivable.</font></p> </div>
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.83 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0107 pure
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
688000 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.62
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.92
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.62
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4400000 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.74
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.47
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0170 pure
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
177146 shares
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0px; MARGIN-LEFT: 2%; MARGIN-TOP: 18px"> <font style="FONT-FAMILY: Times New Roman" size="2"><b><i><u>Use of Estimates</u></i></b></font></p> <p style="MARGIN-BOTTOM: 0px; MARGIN-TOP: 6px"><font style="FONT-FAMILY: Times New Roman" size="2">Accounting estimates are based on historical experience and other factors that are considered reasonable under the circumstances. Estimates are used in determining such items as provisions for sales returns, rebates and incentives, chargebacks, and other sales allowances; depreciable/amortizable lives; asset impairments; valuation allowance on deferred taxes; probabilities of achievement of performance conditions for certain equity awards; amounts recorded for licensing revenue; contingencies and accruals; and valuations of derivative and long-term debt instruments. Because of the uncertainties inherent in such estimates, actual results may differ from these estimates. Management periodically evaluates estimates used in the preparation of the consolidated financial statements for continued reasonableness.</font></p> </div>
CY2016 dei Entity Registrant Name
EntityRegistrantName
AMARIN CORP PLC\UK
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.62
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y3M18D
CY2016 us-gaap Valuation Allowances And Reserves Period Increase Decrease
ValuationAllowancesAndReservesPeriodIncreaseDecrease
13276000
CY2016 us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
104601000
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
17951000
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1094000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
6500000
CY2016 us-gaap Revenues
Revenues
130084000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21000
CY2016 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
567000
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-48000
CY2016 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
128115000
CY2016 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
127436000
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
128966000
CY2016 us-gaap Payments Of Debt Restructuring Costs
PaymentsOfDebtRestructuringCosts
680000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-65626000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-86350000
CY2016 us-gaap Interest Paid
InterestPaid
17083000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1522000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6171000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13602000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
83000
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1094000
CY2016 us-gaap Licenses Revenue
LicensesRevenue
1118000
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
234000
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
1689000
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
1457000
CY2016 us-gaap Interest Expense
InterestExpense
18677000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-21000
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
64613000
CY2016 us-gaap Gross Profit
GrossProfit
95721000
CY2016 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
8170000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
287000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
64613000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-482000
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-86350000
CY2016 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-86350000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3831000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-8115000
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-76381000
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4001000
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8798000
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-334000
CY2016 us-gaap Depreciation
Depreciation
100000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9969000
CY2016 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
4524000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
13613000
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1033000
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1171000
CY2016 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
500000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
138000
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-19039000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
884000
CY2016 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
375000
CY2016 us-gaap Restricted Stock Expense
RestrictedStockExpense
7000000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
111372000
CY2016 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
77747000
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
7783000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1922000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-409000
CY2016 us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
8705000
CY2016 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-6205000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
63126000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
600000
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49975000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
645000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8710000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-27453000
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
34363000
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
138000
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-143000
CY2016 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
4667000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
13276000
CY2016 us-gaap Operating Expenses
OperatingExpenses
161347000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
287000
CY2016 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
6600000
CY2016 amrn Income Tax Reconciliation Derivative Liabilities
IncomeTaxReconciliationDerivativeLiabilities
-668000
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
32734000
CY2016 amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
-537000
CY2016 amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
14915000
CY2016 amrn Cash Discount Invoice Terms
CashDiscountInvoiceTerms
P30D
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-32321000
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-15772000
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
26633000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-21891000
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2016Q4 us-gaap Sales Revenue Net
SalesRevenueNet
38696000
CY2016 amrn Accounts Receivable Credit Period
AccountsReceivableCreditPeriod
P30D
CY2016 amrn Income Tax Rate Reconciliation Cumulative Translation Adjustment Amount
IncomeTaxRateReconciliationCumulativeTranslationAdjustmentAmount
7385000
CY2016 amrn Valuation Allowances And Reserves Foreign Currency Translation
ValuationAllowancesAndReservesForeignCurrencyTranslation
-4676000
CY2016 amrn Number Of Patients Enrolled And Randomized In Study
NumberOfPatientsEnrolledAndRandomizedInStudy
8175 Patient
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
15933000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-31994000
CY2015Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
52800000
CY2015Q1 amrn Equity Offering Costs
EquityOfferingCosts
700000
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
25543000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-29771000
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
33111000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-13354000
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
17707000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-62853000
CY2015Q2 us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
31300000
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
21483000

Files In Submission

Name View Source Status
0001193125-17-065969-index-headers.html Edgar Link pending
0001193125-17-065969-index.html Edgar Link pending
0001193125-17-065969.txt Edgar Link pending
0001193125-17-065969-xbrl.zip Edgar Link pending
amrn-20161231.xml Edgar Link completed
amrn-20161231.xsd Edgar Link pending
amrn-20161231_cal.xml Edgar Link unprocessable
amrn-20161231_def.xml Edgar Link unprocessable
amrn-20161231_lab.xml Edgar Link unprocessable
amrn-20161231_pre.xml Edgar Link unprocessable
d328533d10k.htm Edgar Link pending
d328533dex1055.htm Edgar Link pending
d328533dex211.htm Edgar Link pending
d328533dex231.htm Edgar Link pending
d328533dex311.htm Edgar Link pending
d328533dex312.htm Edgar Link pending
d328533dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g328533ex10001.jpg Edgar Link pending
g328533g58u15.jpg Edgar Link pending
g328533g81l55.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending